OXT and Alzheimer disease: In 1986, through using a radioimmunoassay, Murray et al., measured OXT, vasopressin (AVP), somatostatin, and β-endorphin levels in the cerebrospinal fluid (CSF) of AD patients and healthy individuals of all ages.